XML 15 R6.htm IDEA: XBRL DOCUMENT v3.22.2.2
Unaudited Condensed Consolidated Statements of Stockholders' Investment - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jul. 30, 2022
Jul. 31, 2021
Jul. 30, 2022
Jul. 31, 2021
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Balance - beginning of period (in shares)     39,611,163  
Balance-beginning of period $ 306,106 $ 439,466 $ 291,515 $ 391,036
Balance - beginning of period (in shares)     26,317,947  
Net income 24,713 46,696 $ 64,060 131,462
Issuance of shares through the Company's equity plans 369 226 907 1,997
Purchase of shares under the stock repurchase program (7,009) (83,164) (29,409) (120,477)
Settlement of net share equity awards   (331) (2,069) (3,178)
Cash dividends declared, $0.25 per common share (3,226) (3,846) (6,505) (3,846)
Stock-based compensation $ 1,589 $ 1,131 $ 4,044 $ 3,183
Balance - ending of period (in shares) 39,829,704 39,578,018 39,829,704 39,578,018
Balance-end of period $ 322,543 $ 400,179 $ 322,543 $ 400,179
Balance - end of period (in shares) 27,000,336 24,472,892 27,000,336 24,472,892
Common Stock        
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Balance - beginning of period (in shares) 39,780,000 39,559,000 39,611,000 39,380,000
Balance-beginning of period $ 398 $ 395 $ 396 $ 394
Issuance of shares through the Company's equity plans (in shares) 50,000 19,000 219,000 198,000
Issuance of shares through the Company's equity plans $ 0 $ 1 $ 2 $ 2
Balance - ending of period (in shares) 39,830,000 39,578,000 39,830,000 39,578,000
Balance-end of period $ 398 $ 396 $ 398 $ 396
Paid-In Capital        
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Balance-beginning of period 205,720 198,356 202,729 194,534
Issuance of shares through the Company's equity plans 369 225 905 1,995
Stock-based compensation 1,589 1,131 4,044 3,183
Balance-end of period 207,678 199,713 207,678 199,713
Retained Earnings        
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Balance-beginning of period 1,058,383 943,718 1,022,317 858,951
Net income 24,713 46,696 64,060 131,462
Cash dividends declared, $0.25 per common share (3,226) (3,846) (6,505) (3,846)
Balance-end of period 1,079,872 986,568 1,079,872 986,568
Treasury Stock        
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Balance-beginning of period $ (958,395) $ (703,003) $ (933,927) $ (662,843)
Balance - beginning of period (in shares) 26,855,000 23,484,000 26,318,000 22,901,000
Purchase of shares under the stock repurchase program (in shares) 145,000 985,000 636,000 1,527,000
Purchase of shares under the stock repurchase program $ (7,009) $ (83,164) $ (29,409) $ (120,477)
Settlement of net share equity awards (in shares)   4,000 46,000 45,000
Settlement of net share equity awards   $ (331) $ (2,069) $ (3,178)
Balance-end of period $ (965,405) $ (786,498) $ (965,405) $ (786,498)
Balance - end of period (in shares) 27,000,000 24,473,000 27,000,000 24,473,000